- Oops!Something went wrong.Please try again later.
Unity Biotechnology, Inc. UBX was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.98 – $12.43 in the past one-month time frame, witnessed a sharp increase yesterday.
The company has not seen any estimate revision in the past month, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Unity Biotechnology currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Unity Biotechnology, Inc. Price
Unity Biotechnology, Inc. price | Unity Biotechnology, Inc. Quote
A better-ranked stock in the Medical – Biomedical and Genetics industry is Emergent BioSolutions Inc. EBS, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report
UNITY Biotechnology, Inc. (UBX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research